Cytoplasmic desmosome formation by H-7 and EGF treatment in cultured fetal rat keratinocytes.
Cytoplasmic desmosomes (CD) are classically found in dyskeratotic cells of many epithelial tumors. Their significance and mechanism of formation remain largely speculative. Recently, we have reported the induction of these structures in rat keratinocytes following a brief treatment with acrylamide, and proposed that protein kinase inhibition may be implicated in their formation. In the present study, we show that protein kinase inhibitor H-7 in the presence of EGF is able to induce CD in rat keratinocytes within half an hour. In serum free medium containing 20 ng/ml of EGF, desmosomal structures at different stages of assembly were obtained using H-7 at concentrations ranging between 20 and 80 microM. No such structures were found at lower concentrations. The plaque diameters were significantly small in comparison with plasma membrane plaques. EGF induced plakoglobin positive membrane invaginations and in the presence of H-7, desmosomal plaques assembled on these membranes as either half desmosomes or as symmetric ones. The present results implicate protein kinase inhibition in CD formation and suggest that EGF provides tubular membrane structures in the cytoplasm on which desmosomes may assemble.
Shabana
A H
AH
Laboratoire de Biologie-Odontologie, Institut Biomédical des Cordeliers, Paris, France.
Amar
L
L
Oboeuf
M
M
Martin
N
N
Forest
N
N
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D003593:Cytoplasm / Q000187:drug effects* / Q000648:ultrastructure; D003896:Desmosomes / Q000187:drug effects* / Q000648:ultrastructure; D005314:Embryonic and Fetal Development / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000187:drug effects / Q000648:ultrastructure; D047428:Protein Kinase Inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000166:cytology / Q000187:drug effects / Q000196:embryology
D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors; D004815:Epidermal Growth Factor; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine